PL2925128T3 - Sposoby kontrolowania ciśnienia krwi i zmniejszania duszności w niewydolności serca - Google Patents

Sposoby kontrolowania ciśnienia krwi i zmniejszania duszności w niewydolności serca

Info

Publication number
PL2925128T3
PL2925128T3 PL13848937T PL13848937T PL2925128T3 PL 2925128 T3 PL2925128 T3 PL 2925128T3 PL 13848937 T PL13848937 T PL 13848937T PL 13848937 T PL13848937 T PL 13848937T PL 2925128 T3 PL2925128 T3 PL 2925128T3
Authority
PL
Poland
Prior art keywords
methods
blood pressure
heart failure
controlling blood
reducing dyspnea
Prior art date
Application number
PL13848937T
Other languages
English (en)
Inventor
Edward C. Spindler Jr.
Loretta M. Itri
Gregory Charles Williams
Ming-yi HU
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of PL2925128T3 publication Critical patent/PL2925128T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL13848937T 2012-10-26 2013-10-26 Sposoby kontrolowania ciśnienia krwi i zmniejszania duszności w niewydolności serca PL2925128T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261719127P 2012-10-26 2012-10-26
PCT/US2013/066990 WO2014066870A1 (en) 2012-10-26 2013-10-26 Methods for controlling blood pressure and reducing dyspnea in heart failure
EP13848937.2A EP2925128B1 (en) 2012-10-26 2013-10-26 Methods for controlling blood pressure and reducing dyspnea in heart failure

Publications (1)

Publication Number Publication Date
PL2925128T3 true PL2925128T3 (pl) 2018-10-31

Family

ID=50545374

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13848937T PL2925128T3 (pl) 2012-10-26 2013-10-26 Sposoby kontrolowania ciśnienia krwi i zmniejszania duszności w niewydolności serca

Country Status (18)

Country Link
US (1) US10881645B2 (pl)
EP (1) EP2925128B1 (pl)
JP (2) JP6329957B2 (pl)
KR (1) KR102299073B1 (pl)
CN (2) CN104968199A (pl)
AU (1) AU2013334081B2 (pl)
BR (1) BR112015009291B1 (pl)
CA (1) CA2889584C (pl)
EA (1) EA030354B1 (pl)
ES (1) ES2671639T3 (pl)
IL (1) IL238462A0 (pl)
MX (1) MX359768B (pl)
NZ (1) NZ708511A (pl)
PL (1) PL2925128T3 (pl)
TR (1) TR201807636T4 (pl)
UA (1) UA117571C2 (pl)
WO (1) WO2014066870A1 (pl)
ZA (1) ZA201503741B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016015208A (es) 2014-05-19 2017-03-23 The Medicines Co Nanoparticulas de clevidipina y composiciones farmaceuticas que las contienen.
KR20210136048A (ko) * 2019-03-05 2021-11-16 윈드트리 세라퓨틱스, 인크. 급성 심부전 (ahf)의 치료를 위한 이스타록심-함유 정맥내 제형
CN114966056B (zh) * 2022-06-08 2024-07-02 四川大学华西医院 筛查急性主动脉夹层的试剂盒和系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9303657D0 (sv) 1993-11-05 1993-11-05 Astra Ab Short-acting dihydropyridines
SE9303744D0 (sv) 1993-11-12 1993-11-12 Astra Ab Pharmaceutical emulsion
SE9804002D0 (sv) 1998-11-23 1998-11-23 Astra Ab New manufacturing process
SG191587A1 (en) 2008-05-16 2013-07-31 Corthera Inc Treating dyspnea associated with acute heart failure with relaxin
HUE047692T2 (hu) 2008-08-01 2020-05-28 Chiesi Farm Spa Gyógyászati készítmények és eljárások stabilizálásukra
PL2320740T3 (pl) 2008-08-01 2014-09-30 The Medicines Co Kompozycje farmaceutyczne klewidypiny oraz sposoby ich wytwarzania z niskim stężeniem zanieczyszczeń
ES2773040T3 (es) * 2009-11-11 2020-07-09 Chiesi Farm Spa Métodos de tratamiento o prevención de trombosis de stent
TW201215392A (en) 2010-06-16 2012-04-16 Gilead Sciences Inc Use of ranolazine for treating pulmonary hypertension
HUE026295T2 (en) * 2010-10-12 2016-06-28 The Medicines Co Clevidipine emulsion formulations containing antimicrobial agents
CN103781479A (zh) * 2011-04-01 2014-05-07 医药公司 用于减轻中风损害的短效二氢吡啶(氯维地平)

Also Published As

Publication number Publication date
CN110840890A (zh) 2020-02-28
ZA201503741B (en) 2022-09-28
WO2014066870A1 (en) 2014-05-01
EP2925128A1 (en) 2015-10-07
BR112015009291A2 (pt) 2017-07-04
EA030354B1 (ru) 2018-07-31
AU2013334081B2 (en) 2017-05-18
AU2013334081A1 (en) 2015-06-11
MX359768B (es) 2018-10-10
EA201590825A1 (ru) 2015-09-30
CA2889584C (en) 2018-08-14
US10881645B2 (en) 2021-01-05
TR201807636T4 (tr) 2018-06-21
CN104968199A (zh) 2015-10-07
IL238462A0 (en) 2015-06-30
EP2925128A4 (en) 2016-06-08
JP2018065875A (ja) 2018-04-26
CA2889584A1 (en) 2014-05-01
EP2925128B1 (en) 2018-04-11
ES2671639T3 (es) 2018-06-07
MX2015005341A (es) 2016-05-24
KR20150104084A (ko) 2015-09-14
BR112015009291B1 (pt) 2021-03-16
JP6329957B2 (ja) 2018-05-23
KR102299073B1 (ko) 2021-09-09
US20140121247A1 (en) 2014-05-01
UA117571C2 (uk) 2018-08-27
JP2015535258A (ja) 2015-12-10
NZ708511A (en) 2018-11-30

Similar Documents

Publication Publication Date Title
HK1226016B (zh) 用於通過控制心房壓力來控制血壓的方法和系統
EP2916725A4 (en) IMPROVED MONITORING DEVICE AND METHOD FOR BLOOD PRESSURE
IL232086A0 (en) Syringe and method for pressure regulation
EP2849681A4 (en) DEVICES AND METHODS FOR REDUCING CARDIAC VALVULAR REGURGITATION
EP2793985A4 (en) SYSTEMS AND METHOD FOR THERAPEUTIC INTRATHORACOAL PRESSURE REGULATION
IL238933A0 (en) Device and method for treating malfunction of a heart valve
HK1207012A1 (en) System for monitoring and controlling organ blood perfusion
IL233921A0 (en) Reversible tissue valve and method
EP2892489A4 (en) INFLATABLE MATTRESS AND CONTROL METHODS
HK1210729A1 (en) Medical pump and method of operating the same
EP2906143A4 (en) SYSTEM AND METHOD FOR CARDIAC TREATMENT
SG11201601294PA (en) Method for producing retinal tissue and retina-related cells
SG11201500606UA (en) Patient interface and method for making same
EP2788075A4 (en) DEVICE AND METHOD FOR REDUCING THE TRANSTHORACOID IMPEDANCE OF A PATIENT
EP2811897A4 (en) MEDICAL TERMINAL AND APPLICATION METHOD
EP2566386A4 (en) DEVICES AND METHODS FOR CONTROLLING BLOOD PRESSURE
IL239030A0 (en) Devices and methods for replacing the function of heart valves
SG10201608056SA (en) Valve and hydraulic controller
HK1208617A1 (en) Compression and decompression control system and vascular strengthening method
SG11201405681XA (en) Valve and hydraulic controller
EP2891465A4 (en) MEDICAL SYSTEM AND METHOD OF OPERATION
HK1213324A1 (zh) 心力衰竭療法的選擇中的生物標記物
HK1213799A1 (zh) 降低與心臟衰竭相關的風險和與其相關的因素的方法
IL239045A0 (en) Tissue binding implant device and method
HK1212772A1 (zh) 血液凝結計和方法